Male Enhancement Gummies: What the Science Actually Shows in 2026

Introduction: The $2.37 Billion Question Men Are Asking in 2026

The sexual enhancement supplement industry was valued at approximately $2.37 billion in 2025 and is projected to reach $4.15 billion by 2032, growing at a compound annual rate of roughly 8.28 percent. That is not a niche market. That is a massive commercial ecosystem built entirely around a single, powerful promise: that a chewable supplement can make a man bigger, harder, or more confident.

Most men reading this have already researched male enhancement gummies. They have scanned ingredient lists, read five-star reviews, noticed how many of those reviews sound suspiciously identical, and walked away skeptical. This article is written for that skepticism.

The purpose here is straightforward: to examine what peer-reviewed science actually shows about male enhancement gummies in 2026. Not opinion. Not affiliate marketing dressed up as journalism. A clear-eyed look at the evidence, followed by an honest presentation of the one non-surgical option with clinically measurable results that most men in this position have never encountered.

This article covers how gummies work (or do not), why the regulatory environment permits misleading claims, what the peer-reviewed evidence actually shows ingredient by ingredient, and what the only non-surgical procedure with documented girth results looks like in practice.

What Male Enhancement Gummies Are, and What They Claim

Male enhancement gummies are, at their core, a delivery format. They are chewable dietary supplements marketed to improve penis size, erectile function, sexual stamina, or testosterone levels. The most commonly marketed ingredients include Tribulus terrestris, L-Arginine, L-Citrulline, maca root, zinc, ginseng, and horny goat weed.

These are the same ingredients found in capsule and pill formats. The only meaningful innovation is the gummy itself. The format offers palatability, a perception of naturalness, easy daily habit formation, and reduced stigma compared to swallowing a pill. A candy coating, however, does not change the pharmacology of what is inside. The delivery format is a marketing advantage, not a biological one.

Gummy marketers make two fundamentally different claims: first, that their product improves erectile function and blood flow, and second, that it increases penis size or girth. These claims require entirely different standards of evidence, and conflating them is the central sleight of hand in this industry.

With a reported 22 percent increase in supplement use for sexual wellness over the previous three years, consumer demand is accelerating, and marketers are responding with increasingly aggressive claims.

The Regulatory Reality: Why Gummies Are Not Required to Prove Anything

The fact that reframes everything: male enhancement gummies are classified by the FDA as dietary supplements, which means they are legally categorized as food, not medication.

Contrast that with prescription drugs. Sildenafil (Viagra) and tadalafil (Cialis) required years of rigorous clinical trials demonstrating both safety and efficacy before earning FDA approval. Supplements are exempt from that entire process. Manufacturers are not required to prove effectiveness or safety before bringing a product to market. The burden of proof is reversed; the FDA can only act after a product is already on shelves and has been shown to cause harm.

The Federal Trade Commission actively combats deceptive supplement advertising, but enforcement is reactive and structurally limited. Companies generate unsubstantiated claims faster than regulators can pursue them. The FTC’s enforcement history includes a $9.2 million asset forfeiture settlement against a single male enhancement supplement company, evidence that deceptive claims are both pervasive and highly profitable.

The professional takeaway is direct: every size-increase claim printed on a gummy label exists in a legal gray zone, not because the evidence supports it, but because the law does not require any evidence at all.

The Hidden Danger: What the FDA Has Actually Found Inside These Products

This is where the conversation shifts from ineffective to genuinely dangerous. The FDA has identified more than 400 sexual-enhancement dietary supplement products tainted with hidden drug ingredients, including undeclared sildenafil and tadalafil.

The clinical danger is severe. Undeclared sildenafil and tadalafil can cause life-threatening drops in blood pressure when combined with nitrate medications commonly prescribed for heart conditions. A man taking a “natural” gummy has no way to anticipate that risk because the label does not disclose it.

The threat is not limited to erectile dysfunction drugs. The CDC documented an outbreak in which 17 patients experienced severe hypoglycemia after consuming a male enhancement supplement marketed as “V8,” which was secretly adulterated with glyburide, a prescription diabetes drug. In one FDA action, laboratory analysis confirmed that a product marketed as NUX Male Enhancement contained both sildenafil and tadalafil as undeclared ingredients.

Independent research has also found that over-the-counter sexual enhancement products may contain sildenafil in quantities far exceeding legal prescription doses, or unknown quantities of tadalafil analogs. The risk is not theoretical; it is documented in federal health agency records. A man taking a gummy purchased online simply cannot know what is actually in it.

What the Science Actually Shows: Ingredient by Ingredient

Setting aside contamination, the more fundamental question is whether any ingredient commonly found in these gummies has peer-reviewed evidence supporting an actual increase in penile size. This is a mechanism-level analysis, not a product review.

Tribulus Terrestris

Systematic reviews show no consistent effect on testosterone levels or sexual function in men with normal baseline testosterone. Tribulus is frequently marketed as a natural testosterone booster, a claim the weight of clinical evidence does not support. Even if a modest testosterone effect existed, elevated testosterone does not alter penile anatomy. The structural reason for this is addressed in the anatomy section below.

L-Arginine and L-Citrulline

These amino acids are precursors to nitric oxide, which supports vasodilation. That mechanism is real and documented. The clinical evidence, however, shows only modest improvements in erectile function, and only in men with mild endothelial dysfunction, not in otherwise healthy men.

Critically, improved blood flow to the penis affects erectile rigidity, not penile anatomy. Vasodilation cannot stretch the tunica albuginea or expand the corpora cavernosa beyond their structural limits. This is the core logical fallacy exploited by affiliate content: conflating “blood flow improvement” with “size increase.” They are not the same claim.

Maca Root

Small clinical trials show improvements in sexual desire, a subjective and self-reported metric, not physical arousal or anatomical measurement. The literature describes this evidence as “promising but not conclusive,” a caveat routinely omitted from marketing copy. Sexual desire and penile size are entirely separate physiological domains. Maca’s limited evidence base addresses one and has no mechanism for touching the other.

The Peer-Reviewed Verdict: No Supplement Has Ever Increased Penile Size

A 2023 Journal of Sexual Medicine systematic review (Roshandel, Koo, Kohler) found no scientific evidence supporting a change in penile size for any supplement product reviewed. The authors concluded, memorably, that “the only thing getting bigger is demand and false hope.”

That conclusion is echoed consistently across reputable sources. Healthline’s 2026 assessment and Medical News Today both state plainly: “There is no clinical evidence to suggest that penis enlargement pills can boost a person’s sexual performance or increase penis length or girth.” Mayo Clinic’s authoritative position is that little scientific support exists for nonsurgical methods to enlarge the penis, and that no trusted medical organization endorses penis surgery for purely cosmetic reasons.

A separate 2023 finding revealed that many male enhancement products contained little to no active ingredients at all, raising questions not only about efficacy but about basic product integrity. A July 2026 fact-check by Factually.co confirmed that no over-the-counter supplement has credible, high-quality evidence showing it increases penile length or permanent girth.

This is not a matter of ongoing debate among researchers. The peer-reviewed consensus is unambiguous and consistent across multiple independent research groups and publication venues.

Why Gummies Cannot Work: The Anatomy Argument

Understanding why no oral supplement can increase penile size is the point competitor content almost universally omits.

Penile size is determined primarily by two structures: the tunica albuginea, the fibrous sheath surrounding the erectile tissue, and the corpora cavernosa, the two cylindrical chambers that fill with blood during an erection. Both are dense connective tissue structures.

No ingredient that can be safely consumed orally and absorbed through the gastrointestinal tract has a documented mechanism for remodeling the tunica albuginea or permanently expanding the corpora cavernosa. A supplement might, in theory, marginally improve blood flow and thereby affect the quality of an erection. It cannot change the structural dimensions of the organ.

It is also worth noting that roughly 85 percent of men concerned about their penis size are actually within the normal range, a statistic that reframes the entire category. For most men, the problem is not anatomical. The gummy category is structurally incapable of delivering on its primary promise regardless of ingredient quality or dosage.

The Psychological Driver: Why Informed Men Still Buy These Products

The desire for enhancement is common, documented, and not a sign of irrationality. It is a genuine concern that the supplement industry has learned to monetize with precision.

Consider the scale of the underlying market. Approximately 322 million men worldwide are projected to experience erectile dysfunction by 2025. Yet treatment rates remain strikingly low: one U.S. population-based survey found ED treatment rates of just 2.6 percent among men aged 18 to 34, despite a prevalence of 26 percent in that group. Most affected men are self-treating with over-the-counter products because they have not pursued a clinical path.

There is also penile dysmorphophobia, a documented psychological condition affecting up to 20 percent of men seeking enhancement, in which perceived inadequacy is disproportionate to objective measurement. This angle is almost entirely absent from competitor content, yet it matters enormously. If the concern is primarily psychological, the solution is not a gummy; it is either a clinical consultation that provides objective measurement and context, or a procedure that produces a measurable, visible result addressing the concern directly.

The professional reader is not naive. He has done the research. The reason he is still considering gummies is likely that he has never encountered a legitimate, non-surgical clinical alternative with documented results. That alternative exists.

The Only Non-Surgical Option With Clinically Measurable Results: Hyaluronic Acid Filler Augmentation

Hyaluronic acid (HA) filler-based penile girth augmentation is the only non-surgical procedure with clinically measurable, repeatable results for actual girth increase. Not erectile function improvement. Documented anatomical change.

HA filler is a biocompatible, medical-grade injectable material used extensively across aesthetic medicine, with a well-established safety profile spanning millions of procedures in other anatomical areas. In this application, the filler is placed beneath the penile skin to add volume and girth. It is a direct, mechanical augmentation that does not depend on blood flow, hormone levels, or any of the indirect physiological pathways that oral supplements attempt to influence.

The distinction from gummies is fundamental. This is not a supplement making an indirect claim through a biological pathway. It is a clinically administered procedure with before-and-after measurements documented in peer-reviewed literature. Because HA fillers can be dissolved with hyaluronidase if a patient is unsatisfied, it also represents a lower-commitment option than any surgical alternative.

What the Peer-Reviewed Evidence Shows for HA Filler Girth Augmentation

The evidence base is substantial and consistent:

Compare this to surgical augmentation, which carries an approximately 53 percent complication rate, including skin necrosis, ulcers, infections, and reoperations. That contrast makes non-surgical HA filler the risk-adjusted superior option for most patients. This is not anecdotal; it is documented across multiple countries, research groups, and journals.

How the Procedure Works: What to Expect

The procedure is non-surgical and performed on an outpatient basis, typically completed in under one hour. No cutting. No general anesthesia.

At the Stoller Medical Group / Penis Enlargement New York City practice, treatment follows a staged approach: multiple sessions rather than a single dramatic procedure. Staging reduces risk, improves symmetry, and allows customization based on individual anatomy and goals.

Results are visible immediately and are designed to look and feel natural in both the flaccid and erect states, while preserving normal sensation and function. Most patients resume normal activity within 10 days, with sexual activity resuming in 7 to 10 days, significantly faster than surgical recovery. Results typically last 18 to 24 months, with optional periodic touch-up sessions for maintenance. A follow-up is generally scheduled 2 to 3 months after the initial treatment to assess results and plan any additional sessions.

Understanding the Investment: Pricing and What It Covers

The procedure is priced by syringe, starting at $7,500. The final cost depends on the patient’s anatomy, goals, and the number of syringes used.

Most men begin with a minimum of 10 syringes, and the average for a first procedure is 15 syringes, with the total investment scaling accordingly based on desired results. This is a one-time clinical procedure with documented results lasting 18 to 24 months, not a recurring monthly subscription to a product with no clinical evidence of efficacy.

Free consultations are available, allowing a prospective patient to receive a personalized anatomical assessment, a realistic discussion of expected results, and a precise cost estimate before committing to anything. For a professional who has already spent money on supplements that do not work, this represents a reallocation of resources toward the only option with a documented clinical outcome.

Why Stoller Medical Group: Experience, Credentials, and Clinical Philosophy

Dr. Roy B. Stoller is a board-certified physician with more than 25 years of experience in aesthetic and restorative medicine and 5 years dedicated specifically to non-surgical male enhancement. The practice has performed over 15,000 enlargement procedures, a volume that establishes clinical expertise and pattern recognition impossible to replicate by a provider who handles only occasional cases.

The clinical philosophy is conservative and outcome-focused: staged treatments for improved symmetry and reduced risk, customized plans based on individual anatomy, and planning centered on proportion and natural aesthetics. Notably, the practice does not offer surgical penile lengthening due to its higher risk profile, a decision that prioritizes patient outcomes over revenue.

The patient experience emphasizes comprehensive consultations, realistic goal-setting, thorough informed consent, detailed aftercare, and strict discretion. With five locations spanning Manhattan, Long Island, Albany, Chadds Ford (Pennsylvania), and Eagan (Minnesota), the practice serves patients across the Northeast and Midwest. Procedures use Belefil®, a hyaluronic acid-based, medical-grade biocompatible filler, administered under hospital-grade sterility protocols.

Gummies vs. HA Filler: A Direct Comparison

Dimension Male Enhancement Gummies HA Filler Augmentation
Clinical evidence No peer-reviewed evidence of size increase Multiple RCTs and systematic reviews documenting measurable girth increase
Mechanism Indirect, unproven pathways that cannot alter anatomy Direct mechanical augmentation with immediate, measurable volume
Safety 400+ FDA-identified tainted products; CDC-documented hospitalizations; no pre-market review Medical-grade material, physician-administered under clinical protocols
Reversibility No result to reverse Fully reversible with hyaluronidase
Regulatory status Classified as food; no proof required before sale Medical procedure under physician supervision and informed consent
Cost structure Recurring monthly cost, no documented outcome Priced by syringe starting at $7,500; results lasting 18 to 24 months

For a man who has done the research and wants a result he can measure, the evidence points in one direction.

Conclusion: The Evidence Has a Clear Answer

Male enhancement gummies constitute a multi-billion dollar category with no peer-reviewed evidence of size increase, a documented contamination risk affecting hundreds of products, and a fundamental anatomical incompatibility with the promise they make. The 2023 Journal of Sexual Medicine systematic review found no scientific evidence supporting a change in penile size for any supplement product reviewed. That conclusion has not been contradicted.

Hyaluronic acid filler-based girth augmentation, by contrast, is the only non-surgical procedure with clinically documented, measurable girth results, supported by randomized controlled trials, systematic reviews, and meta-analyses in peer-reviewed journals.

The science has answered the question. For men who have spent time and money on products that do not work, the path forward is not another supplement subscription; it is a consultation with a qualified clinician.

Take the Next Step: Schedule a Free Consultation

Stoller Medical Group / Penis Enlargement New York City offers free consultations that include a personalized anatomical assessment, a realistic discussion of expected results, and a precise cost estimate.

This is a no-obligation conversation with a board-certified physician who has performed over 15,000 procedures. Consultations are available across five locations: Manhattan, Long Island, Albany, Pennsylvania, and Minnesota.

The key differentiators are straightforward: 15,000+ procedures performed, a 10-day recovery, 80 to 90 percent permanent improvement in girth and volume, results lasting 18 to 24 months, and a natural appearance and feel.

Schedule a free consultation today and speak directly with a physician who specializes exclusively in non-surgical male enhancement.